Improvement of anticoagulant treatment using a dynamic decision support algorithm: A Danish Cohort study

Thrombosis Research

Volumn 133, Issue 3, 2014, Pages 375-379

  Nielsen, Peter Brønnum ^a   Lundbye Christensen, Søren ^b   Rasmussen, Lars Hvilsted ^a   Larsen, Torben Bjerregaard ^a,b  

^a AALBORG UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Computer assisted drug therapy; drug dosage calculation; international normalised ratio; statistical model; warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ALGORITHM; COHORT ANALYSIS; DECISION SUPPORT SYSTEM; DENMARK; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED;

ALGORITHMS; ANTICOAGULANTS; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; DENMARK; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; WARFARIN;

EID: 84893932995     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.12.042     Document Type: Article

References (33)

1. ISMAAP. International Self-Monitoring Association of Oral Anticoagulated Patients We Motiv Patients to Tak Control Their Own Oral Anticoagulation Ther 2013
2. D.A. Garcia, and M.J. Schwartz Warfarin therapy: tips and tools for better control J Fam Pract 60 2011 70 75
3. M.C. De Assis, E.R. Rabelo, C.W. Avila, C.A. Polanczyk, and L.E. Rohde Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial Circulation 120 2009 1115 1122 [3 pp. following 1122]
4. P.B. Nielsen, E.H. Eriksen, R.T. Milthers, and O.K. Hejlesen Assessing importance of dietary data in anticoagulation treatment Stud Health Technol Inform 150 2009 782 786
5. M.V. Holmes, B.J. Hunt, and M.J. Shearer The role of dietary vitamin K in the management of oral vitamin K antagonists Blood Rev 26 2012 1 14
6. C. Van Walraven, A. Jennings, N. Oake, D. Fergusson, and A.J. Forster Effect of study setting on anticoagulation control: a systematic review and metaregression Chest 129 2006 1155 1166
7. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briët A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
8. S.J. Connolly, J. Pogue, J. Eikelboom, G. Flaker, P. Commerford, and M.G. Franzosi et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range Circulation 118 2008 2029 2037
9. W.L. Baker, D.A. Cios, S.D. Sander, and C.I. Coleman Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States J Manag Care Pharm 15 2009 244 252
10. S. Kaatz Determinants and measures of quality in oral anticoagulation therapy J Thromb Thrombolysis 25 2008 61 66
11. J.J. You, D.E. Singer, P.A. Howard, D.A. Lane, M.H. Eckman, and M.C. Fang et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
12. K.W. Phillips, and J. Ansell Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management Expert Rev Cardiovasc Ther 6 2008 57 70
13. M. Lind, M. Fahlén, M. Kosiborod, B. Eliasson, and A. Odén Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation Thromb Res 129 2012 32 35
14. M. Connock, C. Stevens, A. Fry-Smith, S. Jowett, D. Fitzmaurice, and D. Moore et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling Health Technol Assess 11 2007 iii iv [ix-66]
15. J.M. Hasenkam, L. Knudsen, H.H. Kimose, H. Grønnesby, J. Attermann, and N.T. Andersen et al. Practicability of patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. A pilot investigation Thromb Res 85 1997 77 82
16. C. Heneghan, A. Ward, R. Perera, C. Bankhead, A. Fuller, and R. Stevens et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data Lancet 379 2012 322 334
17. D.A. Fitzmaurice, F.D. Hobbs, B.C. Delaney, S. Wilson, and R. McManus Review of computerized decision support systems for oral anticoagulation management Br J Haematol 102 1998 907 909
18. G. Chatellier, I. Colombet, and P. Degoulet An overview of the effect of computer-assisted management of anticoagulant therapy on the quality of anticoagulation Int J Med Inform 49 1998 311 320
19. R. Nieuwlaat, S.J. Connolly, J.A. Mackay, L. Weise-Kelly, T. Navarro, and N.L. Wilczynski et al. Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review Implement Sci 6 2011 90
20. M. Cini, C. Legnani, B. Cosmi, G. Guazzaloca, L. Valdrè, and M. Frascaro et al. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms Eur J Clin Pharmacol 68 2012 1167 1174
21. Q. Xu, B. Xu, Y. Zhang, J. Yang, L. Gao, and Y. Zhang et al. Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation Thromb Haemost 108 2012 1132 1140
22. S.A. Lubitz, S.A. Scott, E.B. Rothlauf, A. Agarwal, I. Peter, and D. Doheny et al. Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population J Thromb Haemost 8 2010 1018 1026
23. G.A. McMillin, R. Melis, A. Wilson, M.B. Strong, N.A. Wanner, and R.G. Vinik et al. Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study Ther Drug Monit 32 2010 338 345
24. J.B. Schwartz, L. Kane, K. Moore, and A.H.B. Wu Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin J Am Med Dir Assoc 12 2011 633 638
25. E. Gandara, and P.S. Wells Will there be a role for genotyping in warfarin therapy? Curr Opin Hematol 17 2010 439 443
26. N. Roper, B. Storer, R. Bona, and M. Fang Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing J Mol Diagn 12 2010 283 291
27. P.B. Nielsen, S. Lundbye-Christensen, T.B. Larsen, S.R. Kristensen, and O.K. Hejlesen Monitoring of anticoagulant therapy applying a dynamic statistical model Comput Methods Programs Biomed 110 2013 380 388
28. R.E. Kalman A New Approach to Linear Filtering and Prediction Problems Trans ASME - J Basic Eng 82 1960 35 45
29. L. Poller, M. Keown, S. Ibrahim, G. Lowe, M. Moia, and A.G. Turpie et al. An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage J Thromb Haemost 6 2008 935 943
30. R. Nieuwlaat, L.M. Hubers, A.C. Spyropoulos, J.W. Eikelboom, B.J. Connolly, and H.G.C. Van Spall et al. Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy Thromb Haemost 108 2012 1228 1235
31. B. Grzymala-Lubanski, S. Själander, H. Renlund, P.J. Svensson, and A. Själander Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses Thromb Res 131 2013 130 134
32. E.M. Hylek, S.J. Skates, M.A. Sheehan, and D.E. Singer An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial zfibrillation N Engl J Med 335 1996 540 546
33. J.F. Lassen, J. Kjeldsen, S. Antonsen, P. Hyltoft Petersen, and I. Brandslund Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy Clin Chem 41 1995 1171 1176